Alissa J. Cooper, MD

Articles by Alissa J. Cooper, MD

Lung Cancer State of the Science Summit Recap | Chaired by: Isabel Preeshagul, DO, MBS

Lung Cancer State of the Science Summit Recap | Chaired by: Isabel Preeshagul, DO, MBS

ByIsabel Preeshagul, DO, MBS,Alissa J. Cooper, MD,Kathryn C. Arbour, MD

October 7th 2024

Isabel Preeshagul, DO, MBS, and colleagues share updates from across the lung cancer space as discussed in a recent State of the Science Summit.

Alissa J. Cooper, MD

Dr Cooper on Considerations to Help Guide ADC Use in Second-Line NSCLC

ByAlissa J. Cooper, MD

September 5th 2024

Alissa J. Cooper, MD, discusses insights from the TROPION-Lung01 trial that may help guide antibody-drug conjugate use in second-line NSCLC.

Trending on OncLive

T-DXd Improves PFS in First-Line HER2-Mutant NSCLC

Phase 3 eVOLVE-Lung02 Trial of First-Line Volrustomig Is Discontinued in First-Line Metastatic NSCLC

FDA Grants Fast Track Designation to Sapanisertib and Serabelisib Plus Paclitaxel in Advanced Endometrial Cancer

Dr Viansone on ADC Sequencing in Metastatic HER2+ Breast Cancer

Dr Leary on a Neo-Epitope-Based Vaccine With or Without Pembrolizumab in Platinum-Sensitive Recurrent Ovarian Cancer